Press release
Worldwide Insomnia Industry is Expected to Grow CAGR 4.5 % during Forecast Period of 2023
Insomnia is a common sleep disorder. It was estimated that approximately 30 -35% of global population is suffering from this disorder. Disturbance in sleep frequently awaking or difficulty in returning to sleep after awaking are the major complication in insomnia. Treatment of insomnia is given on the basis of the condition or severity of disease. Low dose of antidepressant and no benzodiazepine are normally administer. Increasing social stress, more workload and thinking about future are the major reasons for increasing symptoms like insomnia. Women are more likely to suffer from this disorder. Global insomnia market is growing at a steady rate during past few years and is expected to grow at a CAGR of 4.5% in coming future. Insomnia drug have found its application in treatment of other diseases like Alzheimer’s and Parkinson disease which has help to boost the market of insomnia. The insomnia market is hampered due to patient expiry of Sunovion in 2014 which was a top selling insomnia drug. However the new launches of product like Belsomra by Merck & Co. Inc and E-2006 by Eisai Co. will help to increase the market in coming future. The major driving factor for the insomnia market are increasing number of mental disorder, increase in patient suffering from Alzheimer’s and Parkinson’s disease, increasing workload and stress. Lack of awareness and education, and challenge to provide a cheap drugs compare with other brand can be responsible hampering the market growth.
Get a sample copy of this report at https://www.marketresearchfuture.com/sample_request/545 .
Global Insomnia market is segmented into four geographies- North America, Europe, Asia Pacific and Middle East and Africa. Due to increasing number mental and psychological disorder insomnia market has got fuel for the development. Global insomnia market is dominated by North America. US accounts the biggest market in the world which is followed by Japan. It was estimated the insomnia market in Japan will reach to 400.4 million till 2023.
Global Insomnia Market has been segmented on the basis of types of therapy which comprises Pharmacological therapy which is further sub segmented into benzodiazepines, non-benzodiazepines, melatonin receptor agonists and other. Non Pharmacological therapy which is sub segmented into Relaxation therapy, Cognitive Behavioral Therapy, Sleep Hygiene Education, Stimulus Control, Paradoxical Intention and Other. By drug formulation they are segmented as Capsules, Tablet and others. On the basis of condition of diseases they are poor quality of sleep, sleep maintenance and other.
Majority of market is dominated by
• Eisai, Co. (Japan)
• Pfizer, Inc. (US)
• Merck & Co Inc (US)
• Sanofi (France)
• Takeda Pharmaceutical Company (Japan)
• Meda Consumer Healthcare Inc (US)
• Pernix Therapeutics (US)
• Purdue Pharma L.P. (US)
• Consumer Healthcare Inc. (Canada)
• Dainippon Sumitomo (Japan)
• ECR Pharmaceuticals (US)
• Flynn Pharma (UK)
• Johnson & Johnson (US)
• Astellas (UK)
• Biocodex S A (France)
• Neurim (Switzerland)
• SkyePharma (UK),
• Vanda Pharmaceuticals Inc. (US)
Browse Complete Report at https://www.marketresearchfuture.com/reports/insomnia-market-545 .
Study Objectives Global Insomnia Market Research Report
• To provide the Detail Overview of parent market.
• To provide In-depth market segmentation and sub segmentations.
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide Competitive landscape and key players in the market.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia Pacific and Middle East and Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global insomnia market.
Intended Audience
• Manufacturing and packaging industries.
• Insomnia devices and drug manufacturers
• Insomnia devices and drug suppliers
• Biotechnology Companies
• Bio-Pharmaceutical Companies
• Research and Development (R&D) Companies
• Government Research Laboratories
• Medical Research Institutes
Get a discount at https://www.marketresearchfuture.com/check-discount/545 .
TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL INSOMNIA MARKET, BY TYPES OF THERAPY
5.1 PHARMACOLOGICAL THERAPY
5.1.1 BENZODIAZEPINES
5.1.2 NON-BENZODIAZEPINES
5.1.3 MELATONIN RECEPTOR AGONISTS
5.1.4 OTHER
5.2 NON PHARMACOLOGICAL THERAPY
5.2.1 RELAXATION THERAPY
5.2.2 COGNITIVE BEHAVIORAL THERAPY
5.2.3 SLEEP HYGIENE EDUCATION
5.2.4 STIMULUS CONTRO
5.2.5 PARADOXICAL INTENTION
5.2.6 OTHER
6. GLOBAL INSOMNIA MARKET, BY DRUG FORMULATION
6.1 CAPSULES
6.2 TABLET
6.3 OTHERS.
7. GLOBAL INSOMNIA MARKET, BY DISEASES CONDITION
7.1 POOR QUALITY OF SLEEP
7.2 SLEEP MAINTENANCE
7.3 OTHER.
8. GLOBAL INSOMNIA MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 WESTERN EUROPE
8.3.1.1 GERMANY
8.3.1.2 FRANCE
8.3.1.3 ITALY
8.3.1.3 SPAIN
8.3.1.5 UK
8.3.1.6 REST OF WESTERN EUROPE
8.3.2 EASTERN EUROPE
8.4 ASIA
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 AUSTRALIA
8.4.5 REPUBLIC OF KOREA
8.5 REST OF ASIA-PACIFIC
8.6 MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
8.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
10 COMPANY PROFILE
10.1 EISAI, CO.
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 MERCK & CO INC
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 SANOFI
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENT
10.4 TAKEDA PHARMACEUTICAL COMPANY
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 PFIZER, INC.
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 OTHERS
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Akash Anand
P: +1 646 845 9312
W: www.marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Worldwide Insomnia Industry is Expected to Grow CAGR 4.5 % during Forecast Period of 2023 here
News-ID: 664799 • Views: …
More Releases from Market Research Future
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics.
The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over…
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more.
The Palm Methyl Ester Derivative Market Size was valued at USD 1.5…
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences.
Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2…
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further.
APAC Wallpaper Market Size was valued at USD 0.55…
More Releases for Insomnia
Global Insomnia Industry Analysis By Geography
Stratistics MRC's Insomnia Market report explains company profiling, key segments, market trends, top players and regional, country-level segments.
Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as alone or conjugated with other psychiatric problems. The exact reason for the cause of insomnia is still unknown. It is most common in women and the severity may increase in conditions like postpartum, menopause and pregnancy. Insomnia disorder…
Competitive Analysis: Insomnia Market Behaviour 2017 - 2026
A recent study showed that nearly 20% people across the world are sleep-deprived, and this means that there will be more people in the coming years who could be victims of acute or chronic insomnia. This trend is sublime for players in the global insomnia market as there will be a larger audience to cater and of course, the need for producing alternative treatment methods to suit the varying needs…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market: Trends and Opportunities 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
Insomnia - US Drug Market: Rising Cases Of Insomnia To Be Biggest Driver
Insomnia is one of the common disorders affected to 35% of the worldwide population. Insomnia is primarily classified into primary and secondary subtypes. The number of people suffering from a sleep disorder, insomnia, is increasing in the United States. In the recent past, the launch of new products and drugs to treat insomnia has been benefiting the U.S. insomnia drugs market. The U.S. insomnia market is classified widely, which enables…
